Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response

Overview

Journal Vaccines (Basel)

Date 2022 Oct 27

PMID 36298605

Authors

Avinash Khadela

Vivek P Chavda

Humzah Postwala

Yesha Shah

Priya Mistry

Vasso Apostolopoulos

Affiliations

Soon will be listed here.

Abstract

Tuberculosis is a stern, difficult to treat chronic infection caused by acid-fast bacilli that tend to take a long time to be eradicated from the host's environment. It requires the action of both innate and adaptive immune systems by the host. There are various pattern recognition receptors present on immune cells, which recognize foreign pathogens or its product and trigger the immune response. The epigenetic modification plays a crucial role in triggering the susceptibility of the host towards the pathogen and activating the host's immune system against the invading pathogen. It alters the gene expression modifying the genetic material of the host's cell. Epigenetic modification such as histone acetylation, alteration in non-coding RNA, DNA methylation and alteration in miRNA has been studied for their influence on the pathophysiology of tuberculosis to control the spread of infection. Despite several studies being conducted, many gaps still exist. Herein, we discuss the immunopathophysiological mechanism of tuberculosis, the essentials of epigenetics and the recent encroachment of epigenetics in the field of tuberculosis and its influence on the outcome and pathophysiology of the infection.

Citing Articles

Human immune system: Exploring diversity across individuals and populations.

Hoang Nguyen K, Le N, Nguyen P, Nguyen H, Hoang D, Huynh C Heliyon. 2025; 11(2):e41836.

PMID: 39911431 PMC: 11795082. DOI: 10.1016/j.heliyon.2025.e41836.

Epigenetic Mechanisms Induced by to Promote Its Survival in the Host.

Thomas S, Abhinand K, Menon A, Nair B, Kumar G, Arun K Int J Mol Sci. 2024; 25(21).

PMID: 39519352 PMC: 11546203. DOI: 10.3390/ijms252111801.

Unveiling the promise: Exosomes as game-changers in anti-infective therapy.

Chavda V, Luo G, Bezbaruah R, Kalita T, Sarma A, Deka G Exploration (Beijing). 2024; 4(5):20230139.

PMID: 39439498 PMC: 11491308. DOI: 10.1002/EXP.20230139.

Toll-Like Receptor Genes and Risk of Latent Tuberculosis Infection in People Infected with HIV-1.

Salamaikina S, Kulabukhova E, Korchagin V, Khokhlova O, Mironov K, Akimkin V Viruses. 2024; 16(9).

PMID: 39339847 PMC: 11436194. DOI: 10.3390/v16091371.

Transcriptome analysis of the diseased intervertebral disc tissue in patients with spinal tuberculosis.

Xu T, Fan W, Chen C, Feng K, Sheng X, Wang H BMC Med Genomics. 2024; 17(1):205.

PMID: 39135040 PMC: 11318271. DOI: 10.1186/s12920-024-01981-w.

References

Borchert G, Lanier W, Davidson B . RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006; 13(12):1097-101. DOI: 10.1038/nsmb1167. View

Peterson C, Laniel M . Histones and histone modifications. Curr Biol. 2004; 14(14):R546-51. DOI: 10.1016/j.cub.2004.07.007. View

Liang S, Song Z, Wu Y, Gao Y, Gao M, Liu F . MicroRNA-27b Modulates Inflammatory Response and Apoptosis during Infection. J Immunol. 2018; 200(10):3506-3518. DOI: 10.4049/jimmunol.1701448. View

Kumar P, Agarwal R, Siddiqui I, Vora H, Das G, Sharma P . ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner. Immunol Cell Biol. 2011; 90(4):411-20. DOI: 10.1038/icb.2011.54. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Falkenberg K, Johnstone R . Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014; 13(9):673-91. DOI: 10.1038/nrd4360. View

Parida A, Bairy K, Chogtu B, Magazine R, Vidyasagar S . Comparison of Directly Observed Treatment Short Course (DOTS) with Self-Administered Therapy in Pulmonary Tuberculosis in Udupi District of Southern India. J Clin Diagn Res. 2014; 8(8):HC29-31. PMC: 4190739. DOI: 10.7860/JCDR/2014/8865.4721. View

Loffek S, Schilling O, Franzke C . Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2010; 38(1):191-208. DOI: 10.1183/09031936.00146510. View

Koo M, Subbian S, Kaplan G . Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages. Cell Commun Signal. 2012; 10(1):2. PMC: 3317440. DOI: 10.1186/1478-811X-10-2. View

10.

Schaberg T, Forssbohm M, Hauer B, Kirsten D, Kropp R, Loddenkemper R . [Guidelines for drug treatment of tuberculosis in adults and childhood]. Pneumologie. 2001; 55(11):494-511. DOI: 10.1055/s-2001-18498. View

11.

Hunter R . Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis. Tuberculosis (Edinb). 2016; 97:8-17. PMC: 4795183. DOI: 10.1016/j.tube.2015.11.010. View

12.

Singh V, Prakhar P, Rajmani R, Mahadik K, Borbora S, Balaji K . Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival. J Infect Dis. 2017; 216(4):477-488. DOI: 10.1093/infdis/jix322. View

13.

Sharma N, Shariq M, Quadir N, Singh J, Sheikh J, Hasnain S . Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival. Front Immunol. 2021; 12:696491. PMC: 8311496. DOI: 10.3389/fimmu.2021.696491. View

14.

Sharma G, Sowpati D, Singh P, Khan M, Ganji R, Upadhyay S . Genome-wide non-CpG methylation of the host genome during M. tuberculosis infection. Sci Rep. 2016; 6:25006. PMC: 4845000. DOI: 10.1038/srep25006. View

15.

Liu C, Liu H, Ge B . Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017; 14(12):963-975. PMC: 5719146. DOI: 10.1038/cmi.2017.88. View

16.

Aung H, Schroder K, Himes S, Brion K, van Zuylen W, Trieu A . LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 2006; 20(9):1315-27. DOI: 10.1096/fj.05-5360com. View

17.

Das A, Dattagupta N, Sridhar C, Wu W . A novel thiocationic liposomal formulation of antisense oligonucleotides with activity against Mycobacterium tuberculosis. Scand J Infect Dis. 2003; 35(3):168-74. DOI: 10.1080/00365540310000102. View

18.

Lugrin J, Ciarlo E, Santos A, Grandmaison G, dos Santos I, Le Roy D . The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock. Biochim Biophys Acta. 2013; 1833(6):1498-510. DOI: 10.1016/j.bbamcr.2013.03.004. View

19.

Deutsch-Feldman M, Pratt R, Price S, Tsang C, Self J . Tuberculosis - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(12):409-414. PMC: 7993554. DOI: 10.15585/mmwr.mm7012a1. View

20.

Jasenosky L, Scriba T, Hanekom W, Goldfeld A . T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015; 264(1):74-87. DOI: 10.1111/imr.12274. View